Truist Assumes Coverage of Revolution Medicines (RVMD), Lifts PT
Revolution Medicines, Inc. (NASDAQ:RVMD) is one of the best medical stocks to invest in according to billionaires. Truist assumed coverage of Revolution Medicines, Inc.
Revolution Medicines Inc. (RVMD)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Farallon Capital Thomas Steyer | 13,604,796 | $1,323,066,411 | -7% | 7.54% |
| 2. | Baker Bros. Advisors Julian Baker And Felix Baker | 9,555,357 | $929,258,468 | +2% | 5.34% |
| 3. | Paradigm Biocapital Advisors Senai Asefaw | 6,655,703 | $647,267,117 | +1% | 13.23% |
| 4. | Adage Capital Management Phill Gross And Robert Atchinson | 5,475,611 | $532,503,170 | +149% | 0.82% |
| 5. | Biotechnology Value Fund / BVF Inc Mark Lampert | 2,856,782 | $277,822,050 | -15% | 8.85% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $46.00 | 760,869 | $34,999,974.00 | 760,869 | 2024-12-05 | Filing | |
| $46.00 | 543,478 | $24,999,988.00 | 2,096,612 | 2024-12-05 | Filing | |
| $20.85 | 6,200 | $129,270.00 | 1,553,134 | 2023-03-10 | Filing | |
| $20.43 | 93,800 | $1,916,334.00 | 1,546,934 | 2023-03-10 | Filing | |
| $22.00 | 318,181 | $6,999,982.00 | 618,181 | 2023-03-07 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $134.34 | 400 | $53,734.00 | 54,400 | 2026-04-27 | Filing | |
| $132.88 | 1,049 | $139,387.76 | 54,800 | 2026-04-27 | Filing | |
| $131.66 | 1,671 | $220,007.03 | 55,849 | 2026-04-27 | Filing | |
| $150.09 | 120,000 | $18,010,488.00 | 276,698 | 2026-04-15 | Filing | |
| $97.21 | 400 | $38,882.84 | 54,400 | 2026-03-25 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 11,212,706 | $1,090,435,565 | 0.02% | |
| 2. | 9,766,496 | $949,537,126 | 0.45% | |
| 3. | 8,464,314 | $823,154,497 | 0.04% | |
| 4. | 8,362,284 | $813,232,119 | 0.02% | |
| 5. | 7,601,087 | $739,205,711 | 52.02% |
News See All
12 Best Medical Stocks to Invest In According to Billionaires
Talking about at what point bond yields create a meaningful risk to investors, she was of the view that if they get above the 5% range, then this “correction” or pullback will be justified.
Needham Keeps Buy Rating on Revolution Medicines (RVMD) Despite Wider Loss
Tom Steyer ranks among the list of the richest hedge fund managers in the world. Revolution Medicines, Inc.
16 Richest Hedge Fund Managers in the World
Fiscal year 2025, aided by an AI-powered stock market surge, proved to be a phenomenal year for hedge fund managers.
Revolution Medicines (RVMD) Receives FDA's "Safe to Proceed" Letter for Daraxonrasib
Revolution Medicines, Inc. (NASDAQ:RVMD) is one of the best performing healthcare stocks so far in 2026. Revolution Medicines, Inc. (NASDAQ:RVMD) announced on May 1 that the U.S.
10 Best Performing Healthcare Stocks So Far in 2026
She was of the view that the backdrop at present is featuring geopolitical tensions, Fed policy uncertainty, inflation concerns, and still, it is incredible that the stock market is at record highs.
Revolution Medicines, Inc. (NASDAQ:RVMD) Q1 2026 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Revolution Medicines Q1 2026 Earnings Call. [Operator Instructions] Please be advised that today's conference is being recorded.
Billionaire Tom Steyer's 10 Stock Picks with Huge Upside Potential
Tom Steyer, the billionaire investor and founder of Farallon Capital, has undergone a profound evolution from a pioneer of absolute-return hedge fund strategies to a leading architect of climate capitalism...
10 Best Stocks to Buy in a Rising Market According to Wall Street Analysts
The equity market remains bullish, driven by a record-setting trend fueled by renewed enthusiasm for artificial intelligence.
12 Takeover Rumors Targeted by Short Sellers
Takeover chatter can lift a stock, but it does not force short sellers to leave. That tension sits at the center of this list.
Hedge Fund Resource Center